212 related articles for article (PubMed ID: 34171743)
1. A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI.
Nikpanah M; Xu Z; Jin D; Farhadi F; Saboury B; Ball MW; Gautam R; Merino MJ; Wood BJ; Turkbey B; Jones EC; Linehan WM; Malayeri AA
Clin Imaging; 2021 Sep; 77():291-298. PubMed ID: 34171743
[TBL] [Abstract][Full Text] [Related]
2. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
3. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
[TBL] [Abstract][Full Text] [Related]
4. Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning.
Baghdadi A; Aldhaam NA; Elsayed AS; Hussein AA; Cavuoto LA; Kauffman E; Guru KA
BJU Int; 2020 Apr; 125(4):553-560. PubMed ID: 31901213
[TBL] [Abstract][Full Text] [Related]
5. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
Wentland AL; Yamashita R; Kino A; Pandit P; Shen L; Brooke Jeffrey R; Rubin D; Kamaya A
Abdom Radiol (NY); 2023 Feb; 48(2):642-648. PubMed ID: 36370180
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
8. A CT-based radiomics nomogram for differentiation of small masses (< 4 cm) of renal oncocytoma from clear cell renal cell carcinoma.
Li X; Ma Q; Tao C; Liu J; Nie P; Dong C
Abdom Radiol (NY); 2021 Nov; 46(11):5240-5249. PubMed ID: 34268628
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study.
Dunn M; Linehan V; Clarke SE; Keough V; Nelson R; Costa AF
AJR Am J Roentgenol; 2022 Nov; 219(5):793-803. PubMed ID: 35642765
[No Abstract] [Full Text] [Related]
10. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
Qu JY; Jiang H; Song XH; Wu JK; Ma H
Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
12. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
[TBL] [Abstract][Full Text] [Related]
13. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.
Moldovanu CG; Petresc B; Lebovici A; Tamas-Szora A; Suciu M; Crisan N; Medan P; Buruian MM
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33126571
[No Abstract] [Full Text] [Related]
16. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation.
Thaiss WM; Bedke J; Kruck S; Spira D; Stenzl A; Nikolaou K; Horger M; Kaufmann S
World J Urol; 2019 Jul; 37(7):1339-1346. PubMed ID: 30324296
[TBL] [Abstract][Full Text] [Related]
17. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
[TBL] [Abstract][Full Text] [Related]
18. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
[TBL] [Abstract][Full Text] [Related]
19. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
20. Deep learning based classification of solid lipid-poor contrast enhancing renal masses using contrast enhanced CT.
Oberai A; Varghese B; Cen S; Angelini T; Hwang D; Gill I; Aron M; Lau C; Duddalwar V
Br J Radiol; 2020 Jul; 93(1111):20200002. PubMed ID: 32356484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
